SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Gómez Garcia Encarna B) "

Sökning: WFRF:(Gómez Garcia Encarna B)

  • Resultat 11-13 av 13
  • Föregående 1[2]
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  •  
12.
  • Mulligan, Anna Marie, et al. (författare)
  • Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
  • 2011
  • Ingår i: Breast cancer research : BCR. - 1465-542X. ; 13:6
  • Tidskriftsartikel (refereegranskat)abstract
    • ABSTRACT: INTRODUCTION: Previous studies have demonstrated that common breast cancer susceptibility alleles are differentially associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. It is currently unknown how these alleles are associated with different breast cancer subtypes in BRCA1 and BRCA2 mutation carriers defined by estrogen (ER) or progesterone receptor (PR) status of the tumor. METHODS: We used genotype data on up to 11,421 BRCA1 and 7,080 BRCA2 carriers, of whom 4,310 had been affected with breast cancer and had information on either ER or PR status of the tumor, to assess the associations of twelve loci with breast cancer tumor characteristics. Associations were evaluated using a retrospective cohort approach. RESULTS: The results suggested stronger associations with ER-positive breast cancer than ER-negative for eleven loci in both BRCA1 and BRCA2 carriers. Among BRCA1 carriers, SNP rs2981582 (FGFR2) exhibited the biggest difference based on ER status (per-allele HR for ER-positive=1.35, 95%CI:1.17-1.56 vs HR=0.91, 95%CI:0.85-0.98 for ER-negative, P-heterogeneity=6.5e-6). In contrast, SNP rs2046210 at 6q25.1 near ESR1 was primarily associated with ER-negative breast cancer risk for both BRCA1 and BRCA2 carriers. In BRCA2 carriers, SNPs in FGFR2, TOX3, LSP1, SLC4A7/NEK10, 5p12, 2q35, and1p11.2 were significantly associated with ER-positive but not ER-negative disease. Similar results were observed when differentiating breast cancer cases by PR status. CONCLUSIONS: The associations of the twelve SNPs with risk for BRCA1 and BRCA2 carriers differ by ER-positive or ER-negative breast cancer status. The apparent differences in SNP associations between BRCA1 and BRCA2 carriers, and non-carriers, may be explicable by differences in the prevalence of tumor subtypes. As more risk modifying variants are identified, incorporating these associations into breast cancer subtype-specific risk models may improve clinical management for mutation carriers.
  •  
13.
  • Schrijver, Lieske H, et al. (författare)
  • Oral Contraceptive Use and Breast Cancer Risk : Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
  • Ingår i: JNCI Cancer Spectrum. - : Oxford University Press. - 2515-5091. ; 2:2
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: For BRCA1 and BRCA2 mutation carriers, the association between oral contraceptive preparation (OCP) use and breast cancer (BC) risk is still unclear.Methods: Breast camcer risk associations were estimated from OCP data on 6030 BRCA1 and 3809 BRCA2 mutation carriers using age-dependent Cox regression, stratified by study and birth cohort. Prospective, left-truncated retrospective and full-cohort retrospective analyses were performed.Results: For BRCA1 mutation carriers, OCP use was not associated with BC risk in prospective analyses (hazard ratio [HR] = 1.08, 95% confidence interval [CI] = 0.75 to 1.56), but in the left-truncated and full-cohort retrospective analyses, risks were increased by 26% (95% CI = 6% to 51%) and 39% (95% CI = 23% to 58%), respectively. For BRCA2 mutation carriers, OCP use was associated with BC risk in prospective analyses (HR = 1.75, 95% CI = 1.03 to 2.97), but retrospective analyses were inconsistent (left-truncated: HR = 1.06, 95% CI = 0.85 to 1.33; full cohort: HR = 1.52, 95% CI = 1.28 to 1.81). There was evidence of increasing risk with duration of use, especially before the first full-term pregnancy (BRCA1: both retrospective analyses, P < .001 and P = .001, respectively; BRCA2: full retrospective analysis, P = .002).Conclusions: Prospective analyses did not show that past use of OCP is associated with an increased BC risk for BRCA1 mutation carriers in young middle-aged women (40-50 years). For BRCA2 mutation carriers, a causal association is also not likely at those ages. Findings between retrospective and prospective analyses were inconsistent and could be due to survival bias or a true association for younger women who were underrepresented in the prospective cohort. Given the uncertain safety of long-term OCP use for BRCA1/2 mutation carriers, indications other than contraception should be avoided and nonhormonal contraceptive methods should be discussed.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-13 av 13
  • Föregående 1[2]
Typ av publikation
tidskriftsartikel (13)
Typ av innehåll
refereegranskat (13)
Författare/redaktör
Spurdle, Amanda B. (17)
Domchek, Susan M. (15)
Evans, D. Gareth (14)
Easton, Douglas F. (14)
Antoniou, Antonis C. (14)
Sinilnikova, Olga M. (14)
visa fler...
Singer, Christian F. (14)
Hansen, Thomas V. O. (14)
Couch, Fergus J. (14)
Benitez, Javier (13)
Greene, Mark H. (13)
Neuhausen, Susan L (12)
Andrulis, Irene L. (12)
Frost, Debra (12)
Nathanson, Katherine ... (12)
Gerdes, Anne-Marie (12)
Mai, Phuong L. (12)
Godwin, Andrew K. (12)
Karlan, Beth Y. (12)
Nevanlinna, Heli (11)
John, Esther M (11)
Meindl, Alfons (11)
Thomassen, Mads (11)
McGuffog, Lesley (11)
Healey, Sue (11)
van der Luijt, Rob B ... (11)
Wappenschmidt, Barba ... (11)
Engel, Christoph (11)
Arnold, Norbert (11)
Osorio, Ana (11)
Caligo, Maria A. (11)
Meijers-Heijboer, Ha ... (11)
Chenevix-Trench, G (10)
Easton, DF (10)
Chenevix-Trench, Geo ... (10)
Hamann, Ute (10)
Schmutzler, Rita K. (10)
Antoniou, AC (10)
Izatt, Louise (10)
Mazoyer, Sylvie (10)
Garcia, Encarna B. G ... (10)
Niederacher, Dieter (10)
Radice, Paolo (10)
Simard, Jacques (10)
Offit, Kenneth (10)
Healey, S (10)
McGuffog, L (10)
Kruse, Torben A. (10)
Adlard, Julian (10)
Davidson, Rosemarie (10)
visa färre...
Lärosäte
Lunds universitet (8)
Uppsala universitet (4)
Linköpings universitet (4)
Karolinska Institutet (4)
Umeå universitet (3)
Göteborgs universitet (1)
Språk
Engelska (13)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (13)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy